Michael Zinda - Nov 23, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Nov 23, 2021
Transactions value $
$91,948
Form type
4
Date filed
12/6/2021, 03:47 PM
Previous filing
Nov 17, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $6.75K +4.12K +773.36% $1.64* 4.66K Nov 23, 2021 Direct
transaction RPTX Common Shares Options Exercise $19.4K +11.9K +254.69% $1.64* 16.5K Nov 23, 2021 Direct
transaction RPTX Common Shares Options Exercise $40.4K +19.6K +118.65% $2.06* 36.1K Nov 23, 2021 Direct
transaction RPTX Common Shares Options Exercise $25.4K +10.5K +29.01% $2.43* 46.6K Nov 23, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -4.12K -100% $0.00* 0 Nov 23, 2021 Common Shares 4.12K $1.64 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -11.9K -100% $0.00* 0 Nov 23, 2021 Common Shares 11.9K $1.64 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -19.6K -35.72% $0.00 35.3K Nov 23, 2021 Common Shares 19.6K $2.06 Direct F2
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -10.5K -7.05% $0.00 138K Nov 23, 2021 Common Shares 10.5K $2.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F3 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.